Press Releases

Search Press Releases:

Search Input

• All News
• 2021
• 2020
• 2019
• 2018
• 2017
• 2016
• 2015
• 2014
• 2013
• 2012
• 2011
• 2010

Tonix Pharmaceuticals Announces that Results from a Preclinical Study of TNX-1900 are Posted at the AAN Sports Concussion Virtual Conference

August 4, 2020 • 7:00 AM EDT

Tonix Pharmaceuticals to Participate in SNN Network Virtual Investor Conference

July 30, 2020 • 7:00 AM EDT

Tonix Pharmaceuticals Announces that Results from a Preclinical Study of TNX-1900 Will be Presented in a Poster at the AAN Sports Concussion Virtual Conference

July 27, 2020 • 7:00 AM EDT

Tonix Pharmaceuticals Holding Corp. Announces Rescheduling of Special Meeting of Stockholders

July 21, 2020 • 4:45 PM EDT

Tonix Pharmaceuticals Announces Research Collaboration to Develop Precision Medicine Techniques for COVID-19 Vaccines and Therapeutics

July 16, 2020 • 9:00 AM EDT

Tonix Pharmaceuticals Holding Corp. Closes $10.5 Million Common Stock Registered Direct Offering

July 15, 2020 • 5:00 PM EDT

Tonix Pharmaceuticals Holding Corp. Prices $10,500,000 Common Stock Offering

July 13, 2020 • 1:11 PM EDT

Tonix Pharmaceuticals Enters into Research and Exclusive License Option Agreement with Kansas State University to Develop Vaccine Against COVID-19

July 13, 2020 • 7:00 AM EDT

Tonix Pharmaceuticals Completes Enrollment in Phase 3 RELIEF Trial of TNX-102 SL for Management of Fibromyalgia

July 10, 2020 • 7:00 AM EDT

Tonix Pharmaceuticals Plans Massachusetts R&D Facility to Accelerate Clinical Development of Vaccines and Protein-Based Therapeutics

July 7, 2020 • 7:00 AM EDT

• « Previous
• 1...
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• ...41
• Next »